Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Blood Advances
|
August 26, 2025
Improvements in Health-Related Quality of Life in Patients with Severe Sickle Cell Disease After Exagamglogene Autotemcel
Akshay Sharma, Franco Locatelli, Monica Bhatia, et al.
Pediatric Blood & Cancer
|
March 13, 2018
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study
Christopher C Dvorak, Prakash Satwani, Elliot Stieglitz, et al.
Blood Advances
|
August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene Autotemcel
Josu de la Fuente, Haydar Frangoul, Peter Lang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 26, 2013
Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group
Rudolph Kirk R Schultz, Kevin Scott Baker, Jaap J Boelens, et al.
The New England Journal of Medicine
|
December 7, 2020
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Haydar Frangoul, David Altshuler, M Domenica Cappellini, et al.
Blood
|
February 7, 2012
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?
Juliana F Fernandes, Vanderson Rocha, Myriam Labopin, et al.
The New England Journal of Medicine
|
April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
Franco Locatelli, Peter Lang, Donna Wall, et al.
The New England Journal of Medicine
|
April 25, 2024
Exagamglogene Autotemcel for Severe Sickle Cell Disease
Haydar Frangoul, Franco Locatelli, Akshay Sharma, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Blood Advances
|
August 26, 2025
Improvements in Health-Related Quality of Life in Patients with Severe Sickle Cell Disease After Exagamglogene Autotemcel
Akshay Sharma, Franco Locatelli, Monica Bhatia, et al.
Pediatric Blood & Cancer
|
March 13, 2018
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study
Christopher C Dvorak, Prakash Satwani, Elliot Stieglitz, et al.
Blood Advances
|
August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene Autotemcel
Josu de la Fuente, Haydar Frangoul, Peter Lang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 26, 2013
Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group
Rudolph Kirk R Schultz, Kevin Scott Baker, Jaap J Boelens, et al.
The New England Journal of Medicine
|
December 7, 2020
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Haydar Frangoul, David Altshuler, M Domenica Cappellini, et al.
Blood
|
February 7, 2012
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?
Juliana F Fernandes, Vanderson Rocha, Myriam Labopin, et al.
The New England Journal of Medicine
|
April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
Franco Locatelli, Peter Lang, Donna Wall, et al.
The New England Journal of Medicine
|
April 25, 2024
Exagamglogene Autotemcel for Severe Sickle Cell Disease
Haydar Frangoul, Franco Locatelli, Akshay Sharma, et al.
Page
of 4